Is autologous transplant in relapsed DLBCL patients achieving only a PET(+) PR appropriate in the CAR T-cell era?

由 Shah, Nirav N., Ahn, Kwang W., Litovich, Carlos, He, Yizeng, Sauter, Craig, Fenske, Timothy S., Hamadani, Mehdi
發表在 Blood (2021)

Impact of reduced-intensity conditioning regimens on outcomes in diffuse large B-cell lymphoma undergoing allogeneic transplantation

由 Epperla, Narendranath, Ahn, Kwang W., Khanal, Manoj, Litovich, Carlos, Ahmed, Sairah, Ghosh, Nilanjan, Fenske, Timothy S., Kharfan-Dabaja, Mohamed A., Sureda, Anna, Hamadani, Mehdi
發表在 Transplant Cell Ther (2020)

Higher total body irradiation dose-intensity in fludarabine/TBI-based reduced-intensity conditioning regimen is associated with inferior survival in non-Hodgkin lymphoma patients u...

由 Hamadani, Mehdi, Khanal, Manoj, Ahn, Kwang W., Litovich, Carlos, Chow, Victor A., Eghtedar, Alireza, Karmali, Reem, Winter, Allison, Fenske, Timothy S., Sauter, Craig, Kharfan-Dabaja, Mohamed A., Awan, Farrukh T.
發表在 Biol Blood Marrow Transplant (2020)

Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors

由 Kanate, Abraham S., Mussetti, Alberto, Kharfan-Dabaja, Mohamed A., Ahn, Kwang W., DiGilio, Alyssa, Beitinjaneh, Amer, Chhabra, Saurabh, Fenske, Timothy S., Freytes, Cesar, Gale, Robert Peter, Ganguly, Siddhartha, Hertzberg, Mark, Klyuchnikov, Evgeny, Lazarus, Hillard M., Olsson, Richard, Perales, Miguel-Angel, Rezvani, Andrew, Riches, Marcie, Saad, Ayman, Slavin, Shimon, Smith, Sonali M., Sureda, Anna, Yared, Jean, Ciurea, Stefan, Armand, Philippe, Salit, Rachel, Bolaños-Meade, Javier, Hamadani, Mehdi
發表在 Blood (2016)

Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a C...

由 Epperla, Narendranath, Ahn, Kwang W., Litovich, Carlos, Ahmed, Sairah, Battiwalla, Minoo, Cohen, Jonathon B., Dahi, Parastoo, Farhadfar, Nosha, Farooq, Umar, Freytes, Cesar O., Ghosh, Nilanjan, Haverkos, Bradley, Herrera, Alex, Hertzberg, Mark, Hildebrandt, Gerhard, Inwards, David, Kharfan-Dabaja, Mohamed A., Khimani, Farhad, Lazarus, Hillard, Lazaryan, Aleksandr, Lekakis, Lazaros, Murthy, Hemant, Nathan, Sunita, Nishihori, Taiga, Pawarode, Attaphol, Prestidge, Tim, Ramakrishnan, Praveen, Rezvani, Andrew R., Romee, Rizwan, Shah, Nirav N., Sureda, Ana, Fenske, Timothy S., Hamadani, Mehdi
發表在 J Hematol Oncol (2019)

Lower GVHD and relapse risk in PTCy-based Haploidentical vs Matched Sibling Donor RIC Transplant for Hodgkin Lymphoma.

由 Ahmed, Sairah, Kanakry, Jennifer A., Ahn, Kwang W., Litovich, Carlos, Abdel-Azim, Hisham, Aljurf, Mahmoud, Bacher, Vera Ulrike, Bejanyan, Nelli, Cohen, Jonathon B., Farooq, Umar, Fuchs, Ephraim J., Bolaños-Meade, Javier, Ghosh, Nilanjan, Herrera, Alex F., Hossain, Nasheed M., Inwards, David, Kanate, Abraham S., Martino, Rodrigo, Munshi, Pashna N., Murthy, Hemant, Mussetti, Alberto, Nieto, Yago, Perales, Miguel-Angel, Romee, Rizwan, Savani, Bipin N., Seo, Sachiko, Wirk, Baldeep, Yared, Jean A., Sureda, Ana, Fenske, Timothy S., Hamadani, Mehdi
發表在 Biol Blood Marrow Transplant (2019)

Outcomes of rituximab-BEAM vs BEAM conditioning regimen in patients with diffuse large B-cell lymphoma undergoing autologous transplantation.

由 Jagadeesh, Deepa, Majhail, Navneet S., He, Yizeng, Ahn, Kwang W., Litovich, Carlos, Ahmed, Sairah, Aljurf, Mahmoud, Bacher, Ulrike, Badawy, Sherif M., Bejanyan, Nelli, Cairo, Mitchell, Cerny, Jan, Epperla, Narendranath, Farhadfar, Nosha, Freytes, César O., Gale, Robert Peter, Haverkos, Bradley, Hossain, Nasheed, Inwards, David, Kamble, Rammurti T., Kenkre, Vaishalee P., Lazarus, Hillard M., Lazaryan, Aleksandr, Lekakis, Lazaros, Mei, Matthew, Murthy, Hemant S., Mussetti, Alberto, Nathan, Sunita, Nishihori, Taiga, Olsson, Richard F., Geethakumari, Praveen Ramakrishnan, Savani, Bipin N., Yared, Jean A., Fenske, Timothy S., Kharfan-Dabaja, Mohamed A., Sureda, Anna, Hamadani, Mehdi
發表在 Cancer (2020)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NEUROBLASTOMA: THE CIBMTR EXPERIENCE

由 Hale, Gregory A., Arora, Mukta, Ahn, Kwang W., He, Wensheng, Camitta, Bruce, Bishop, Michael R., Bitan, Menachem, Cairo, Mitchell S., Chan, Kawah, Childs, Richard W., Copelan, Edward, Davies, Stella M., Perez, Miguel A. Diaz, Doyle, John J., Gale, Robert Peter, Vicent, Marta Gonzalez, Horn, Biljana N., Hussein, Ayad A., Jodele, Sonata, Kamani, Naynesh R., Kasow, Kimberly A., Kletzel, Morris, Lazarus, Hillard M., Lewis, Victor A., Myers, Kasiani C., Olsson, Richard, Pulsipher, Michael, Qayed, Muna, Sanders, Jean E., Shaw, Peter J., Soni, Sandeep, Stiff, Patrick J., Stadtmauer, Edward A., Ueno, Naoto T., Wall, Donna A., Grupp, Stephan A.
出版 2013

Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant

由 Scordo, Michael, Wang, Trent P., Ahn, Kwang W., Chen, Yue, Ahmed, Sairah, Awan, Farrukh T., Beitinjaneh, Amer, Chen, Andy, Chow, Victor A., Dholaria, Bhagirathbhai, Epperla, Narendranath, Farooq, Umar, Ghosh, Nilanjan, Grover, Natalie, Hamad, Nada, Hildebrandt, Gerhard C., Holmberg, Leona, Hong, Sanghee, Inwards, David J., Jimenez-Jimenez, Antonio, Karmali, Reem, Kenkre, Vaishalee P., Khimani, Farhad, Klyuchnikov, Evgeny, Krem, Maxwell M., Munshi, Pashna N., Nieto, Yago, Prestidge, Tim, Ramakrishnan Geethakumari, Praveen, Rezvani, Andrew R., Riedell, Peter A., Seo, Sachiko, Shah, Nirav N., Solh, Melhem, Yared, Jean A., Kharfan-Dabaja, Mohamed A., Herrera, Alex, Hamadani, Mehdi, Sauter, Craig S.
發表在 JAMA Oncol (2021)